Skip to main content

Table 1 Comparing characteristics of patients with and without significant fibrosis

From: Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers

Variables Patients without significant fibrosis (F0-1), n = 329 Patients with significant fibrosis (F2-4), n = 126 χ2 value P
Age 29(16-60) 40(17-75) 52.21 < 0.0001
Gender(M/F) 215/114 74/52 1.723 0.189
WBC(109/L) 5.3(2.3-12.2) 4.5(1.3-18.1) 14.51 < 0.0001
RBC(1012/L) 4.8(3.5-4.0) 4.5(2.6-5.7) 9.47 0.002
Hb(g/L) 145(87-173) 141(85-167) 1.79 0.174
Platelet(109/L) 184(46-350) 136(13-246) 80.24 < 0.0001
ALT(U/L) 72.0(6-471) 174.1(11-536) 11.37 < 0.001
AST(U/L) 15.2(11-341) 63.4(11-413) 28.43 < 0.0001
GGT(u/L) 24.9(6-473) 66.5(8-327) 62.14 < 0.0001
ALP(u/L) 106(7-219) 117(19-307) 2.78 0.099
ChE(u/L) 8054(70-20427) 6617(50-12648) 41.28 < 0.0001
TP(g/L) 72.3(49-88.4) 72.1(40-88.3) 0.442 0.501
Alb(g/L) 45.4(11.6-47.0) 43.2(10.9-52.6) 18.14 < 0.0001
TBIL(μmol/L) 13.4(3-138) 15.3(5.5-216) 11.03 < 0.0001
Length of liver biopsy(mm) 14(10-21) 12(11-19) 1.290 0.256
Number of liver biopsy 2.0(1.0-4.0) 2.5(1.0-5.0) 1.621 0.197